Cargando…

Baricitinib for the Management of SARS-CoV-2-Infected Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

Baricitinib is known to reduce mortality and disease progression in COVID-19 patients; however, the data are inconsistent. Therefore, it needs to be explored to further understand the clinical benefits of this drug in the management of COVID-19 patients. Does baricitinib statistically significantly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manoharan, Sivananthan, Ying, Lee Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346539/ https://www.ncbi.nlm.nih.gov/pubmed/35938147 http://dx.doi.org/10.1155/2022/8332819

Ejemplares similares

Does baricitinib reduce mortality and disease progression in SARS-CoV-2 virus infected patients? A systematic review and meta analysis
por: Manoharan, Sivananthan, et al.
Publicado: (2022)

Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(−) Patients: A Comparative Meta-Analysis
por: Manoharan, Sivananthan, et al.
Publicado: (2023)

Baricitinib en el tratamiento de infección por SARS-CoV-2
por: Gutiérrez-Lorenzo, Marta, et al.
Publicado: (2020)

Baricitinib treatment resolves lower airway inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques
por: Hoang, Timothy N., et al.
Publicado: (2020)

Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques
por: Hoang, Timothy N., et al.
Publicado: (2021)

Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection
por: Akbarzadeh-Khiavi, Mostafa, et al.
Publicado: (2021)

Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
por: Li, Huan, et al.
Publicado: (2020)

507. Impact of Baricitinib on Outcomes in Patients Treated with Remdesivir and Dexamethasone for SARS-CoV-2 Pneumonia: A Retrospective Cohort Study
por: Dea, Lauren, et al.
Publicado: (2021)

Risk of preterm birth in maternal influenza or SARS-CoV-2 infection: a systematic review and meta-analysis
por: Wang, Xuan, et al.
Publicado: (2023)

Co-infection associated with SARS-CoV-2 and their management
por: Chavda, Vivek P, et al.
Publicado: (2023)

Updates in Management of SARS-CoV-2 Infection
por: Flisiak, Robert, et al.
Publicado: (2022)

Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis
por: Sah, Pratha, et al.
Publicado: (2021)

Co-infection of SARS-CoV-2 and influenza viruses: A systematic review and meta-analysis
por: Dao, Thi Loi, et al.
Publicado: (2021)

The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal–fetal transmission: a systematic review and meta-analysis
por: Diriba, Kuma, et al.
Publicado: (2020)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Efficacy and safety of baricitinib for the treatment of hospitalized adults with COVID-19: a systematic review and meta-analysis
por: Sun, Jing, et al.
Publicado: (2023)

Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection
por: Jha, Aruni, et al.
Publicado: (2022)

Dexamethasone for treating SARS-CoV-2 infection: a systematic review and meta-analysis
por: Ferreto, Lirane Elize Defante, et al.
Publicado: (2021)

Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2021)

Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2022)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

SARS-CoV-2–Legionella Co-Infections: A Systematic Review and Meta-Analysis (2020–2021)
por: Riccò, Matteo, et al.
Publicado: (2022)

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
por: Richardson, Peter, et al.
Publicado: (2020)

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
por: Cevik, Muge, et al.
Publicado: (2021)

SARS-CoV-2 Infection in Children
por: Lu, Xiaoxia, et al.
Publicado: (2020)

Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials
por: Ma, Kevin Sheng-Kai, et al.
Publicado: (2021)

Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial
por: Young, Bernadette C, et al.
Publicado: (2021)

BARICITINIB IN HOSPITALIZED PATIENTS WITH COVID-19: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
por: SELVARAJ, VIJAIRAM, et al.
Publicado: (2022)

Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial
por: García-García, Irene, et al.
Publicado: (2022)

1946. Efficacy of Approved versus Unapproved Vaccines for SARS-CoV-2 Infection in Randomised Blinded Clinical Trials
por: Navarro, Andrea Perez, et al.
Publicado: (2022)

The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection
por: Huizinga, Gabrielle P, et al.
Publicado: (2020)

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Publicado: (2022)

Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients’ Real Problems: Chronic Dry Cough and Angioedema
por: Manoharan, Sivananthan
Publicado: (2023)

Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials
por: Yang, Zhi-Rong, et al.
Publicado: (2023)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial)
por: Ghati, Nirmal, et al.
Publicado: (2022)

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
por: Chen, Xinhua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u9doj9d001bhhmi5gvfo3g1dk9